DKI

Key Financial Metrics

Key Facts

• Best-efforts offering of up to 4,166,666 Units at $1.20/Unit, plus up to 4,166,666 Pre-Funded Units at $1.1999 each
• Each Unit = 1 Class A ordinary share + 1 warrant exercisable at 170% of offering price ($2.04 assumed), expiring in 6 months
• Warrants include a zero-exercise-price option entitling holders to ~12 Class A shares per warrant with no cash payment
• If all warrants exercised via zero-exercise-price option, up to 52.4 million additional Class A shares issued — total 56.5 million new shares representing ~96.4% of post-offering shares
• No minimum offering amount — company may raise substantially less than the ~$4.75 million net proceeds estimated
• Revenue for six months ended March 31, 2026: ~$5.93 million, up 13.9% YoY from ~$5.20 million
• Gross profit for six months ended March 31, 2026: ~$1.76 million, up 20.9% YoY
• Accumulated deficits of ~$14.2 million as of March 31, 2026
• CEO Hong Zhifang holds ~20.49% of shares but ~97.48% voting power via dual-class structure (150 votes per Class B share)
• After full offering and warrant exercise, Hong would hold ~0.73% of shares but ~52.55% voting power
• Company is a 'controlled company' under Nasdaq rules and may rely on corporate governance exemptions
• Auditor Enrome LLP is Singapore-based and PCAOB-registered; HFCA Act delisting risk if PCAOB access is obstructed
• Company believes it is not subject to CSRC overseas listing filing requirements (mainland China subsidiary accounts for <50% of revenue, assets, and profits)
• Placement agent: Prime Number Capital, LLC; 5% cash fee plus up to $80,000 expense reimbursement
• 180-day lock-up for officers, directors, and 10%+ shareholders; 90-day company lock-up
• Offering priced at significant discount to last sale price of $2.55 on September 29, 2026
• Company previously received Nasdaq minimum bid price deficiency notice (Nov 2025); regained compliance in May 2026

Financial Impact

Maximum gross proceeds ~$5.0 million; net proceeds ~$4.75 million after fees and expenses. Potential dilution of up to 56.5 million new Class A shares (~96.4% of post-offering shares) with no additional proceeds from warrant exercise.

Risk Factors

• Massive dilution: up to 56.5 million new shares (~96.4% of post-offering total) from warrant exercise with zero proceeds to the company
• Best-efforts offering with no minimum — may raise far less than the ~$4.75 million estimated net proceeds
• HFCA Act delisting risk if PCAOB cannot inspect Singapore-based auditor Enrome LLP
• PRC regulatory uncertainty: potential CSRC filing requirements, cybersecurity reviews, or gaming industry restrictions
• Dual-class structure concentrates ~97.5% voting power with CEO; minority shareholders have limited influence
• Company has accumulated deficits of ~$14.2 million and may need additional capital
• No public trading market expected for warrants or pre-funded warrants — limited liquidity for those securities
• Offering priced at significant discount to market ($1.20 vs $2.55 last sale) — signals distressed capital raise
• Nasdaq minimum bid price compliance risk remains; stock previously received deficiency notice
• Substantially all operations in Hong Kong/China — geopolitical and regulatory risks

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

US Market Status